Aifm1tm2Pngr/Aifm1+ Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * FVB/N
|
decreased body size |
J:113016
|
prenatal lethality, incomplete penetrance |
J:113016
|
Aifm1tm2Pngr/Y Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * FVB/N
|
embryonic growth retardation |
J:113016
|
embryonic lethality during organogenesis, complete penetrance |
J:113016
|
Alktm1.1(ALK*F1174L)Heno/Alktm1.1(ALK*F1174L)Heno Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: 129X1/SvJ * C57BL/6 * C57BL/6N * FVB/N * SJL
|
abnormal stellate ganglion morphology |
J:294092
|
normal
neoplasm |
J:294092
|
Artm1Chc/Ar+ Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S/SvEv * C57BL/6J * FVB/N
|
decreased litter size |
J:81789
|
Artm1Chc/Artm1.1Chc Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S/SvEv * C57BL/6J * FVB/N
|
abnormal branching of the mammary ductal tree |
J:87193
|
abnormal lactation |
J:87193
|
abnormal mammary gland morphology |
J:87193
|
abnormal nursing |
J:87193
|
decreased litter size |
J:81789
|
decreased ovary weight |
J:87193
|
decreased oviduct weight |
J:87193
|
decreased uterus weight |
J:87193
|
enlarged thymus |
J:87193
|
Artm1Chc/Y Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S/SvEv * C57BL/6J * FVB/N
|
abnormal anogenital distance |
J:81789
|
abnormal external male genitalia morphology |
J:81789
|
abnormal fat cell morphology |
J:81789,
J:98775
|
abnormal long bone metaphysis morphology |
J:81789
|
abnormal scrotum morphology |
J:81789
|
abnormal seminiferous tubule morphology |
J:118270
|
abnormal Sertoli cell morphology |
J:81789,
J:118270
|
abnormal spermatocyte morphology |
J:118270
|
abnormal spermatogonia morphology |
J:81789
|
abnormal trabecular bone morphology |
J:81789
|
absent epididymis |
J:81789
|
absent external male genitalia |
J:81789
|
absent prostate gland |
J:81789
|
absent seminal vesicle |
J:81789
|
absent vas deferens |
J:81789
|
arrest of male meiosis |
J:118270
|
arrest of spermatogenesis |
J:81789
|
cryptorchism |
J:81789,
J:118270
|
decreased adiponectin level |
J:98775
|
decreased body weight |
J:81789,
J:98775
|
decreased circulating testosterone level |
J:81789,
J:98775,
J:118270
|
decreased response to leptin |
J:81789
|
hyperglycemia |
J:98775
|
hypospadia |
J:81789
|
impaired glucose tolerance |
J:98775
|
increased bone ossification |
J:81789
|
increased circulating glucose level |
J:98775
|
increased circulating insulin level |
J:98775
|
increased circulating leptin level |
J:98775
|
increased circulating triglyceride level |
J:98775
|
increased gonadal fat pad weight |
J:98775
|
increased liver triglyceride level |
J:98775
|
increased osteoclast cell number |
J:81789
|
increased renal fat pad weight |
J:98775
|
increased skeletal muscle triglyceride level |
J:98775
|
increased susceptibility to weight gain |
J:98775
|
increased white adipose tissue amount |
J:98775
|
insulin resistance |
J:98775
|
Leydig cell hypertrophy |
J:81789
|
seminiferous tubule degeneration |
J:118270
|
small penis |
J:81789
|
small seminiferous tubules |
J:118270
|
small testis |
J:118270
|
testicular atrophy |
J:98775
|
testis hypoplasia |
J:81789
|
Bcortm1.1Vjba/Bcor+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: 129S1/Sv * C57BL/6N * FVB/N
|
abnormal placenta labyrinth morphology |
J:296645
|
abnormal placenta morphology |
J:296645
|
abnormal spongiotrophoblast layer morphology |
J:296645
|
asymmetric snout |
J:296645
|
blepharoptosis |
J:296645
|
broad snout |
J:296645
|
cataract |
J:296645
|
cleft palate |
J:296645
|
decreased embryo size |
J:296645
|
embryonic lethality prior to tooth bud stage |
J:296645
|
increased trophoblast giant cell number |
J:296645
|
kinked tail |
J:296645
|
kyphosis |
J:296645
|
microphthalmia |
J:296645
|
neonatal lethality, incomplete penetrance |
J:296645
|
postnatal lethality, incomplete penetrance |
J:296645
|
thin placenta labyrinth |
J:296645
|
Bcortm1.1Vjba/Y Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: 129S1/Sv * C57BL/6N * FVB/N
|
decreased forebrain size |
J:296645
|
embryonic growth retardation |
J:296645
|
embryonic lethality between implantation and placentation, complete penetrance |
J:296645
|
Bmal1tm1.1Ljm/Bmal1tm1.1Ljm Tmem163Tg(ACTB-cre)2Mrt/0
involves: C57BL/6 * FVB/N
|
abnormal circadian behavior |
J:188253
|
decreased locomotor activity |
J:188253
|
Cochtm1Stw/Cochtm1Stw Tmem163Tg(ACTB-cre)2Mrt/?
involves: 129S1/Sv * FVB/N
|
no abnormal phenotype detected |
J:105566
|
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+ Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N
|
cardiac hypertrophy |
J:209629
|
decreased body size |
J:209629
|
embryonic lethality, incomplete penetrance |
J:209629
|
hydrocephaly |
J:209629
|
premature death |
J:209629
|
seizures |
J:209629
|
tremors |
J:209629
|
Dppa2tm1.1Reik/Dppa2+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: C57BL/6 * FVB/N
|
maternal effect |
J:316936
|
Dppa2tm2.1Reik/Dppa2tm2.1Reik Dppa4tm2.1Reik/Dppa4tm2.1Reik Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: C57BL/6 * FVB/N
|
maternal effect |
J:316936
|
Dppa4tm1.1Reik/Dppa4+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: C57BL/6 * FVB/N
|
maternal effect |
J:316936
|
Epb41l3tm1Bhat/Epb41l3tm1.1Bhat Tmem163Tg(ACTB-cre)2Mrt/0
involves: FVB/N
|
abnormal paranodal axoglial junction morphology |
J:173383
|
abnormal paranode morphology |
J:173383
|
Esr1tm1Syeh/Esr1tm1Syeh Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129X1/SvJ * FVB/N
|
abnormal female reproductive system morphology |
J:147191
|
abnormal granulosa cell morphology |
J:147191
|
abnormal male reproductive system morphology |
J:147191
|
abnormal myometrium morphology |
J:147191
|
abnormal ovary morphology |
J:147191
|
abnormal prostate gland branching morphogenesis |
J:147000
|
abnormal prostate gland physiology |
J:147000
|
abnormal reproductive system physiology |
J:147191
|
absent corpus luteum |
J:147191
|
decreased male germ cell number |
J:147000
|
decreased primary ovarian follicle number |
J:147191
|
decreased primordial ovarian follicle number |
J:147191
|
decreased testis weight |
J:147000
|
female infertility |
J:147191
|
impaired ovarian folliculogenesis |
J:147191
|
increased atretic ovarian follicle number |
J:147191
|
increased circulating testosterone level |
J:147000
|
increased total body fat amount |
J:147191
|
male infertility |
J:147000
|
obese |
J:147191
|
oligozoospermia |
J:147000
|
ovary cyst |
J:147191
|
seminiferous tubule degeneration |
J:147000
|
small testis |
J:147000
|
uterus hypoplasia |
J:147191
|
vagina hypoplasia |
J:147191
|
Gdf7tm2Tmj/Gdf7+ Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S1/Sv * FVB/N
|
abnormal forebrain morphology |
J:100435
|
absent choroid plexus |
J:100435
|
open neural tube |
J:100435
|
Grem1tm1Ecan/Grem1+ Nogtm1.1Rmh/Nogtm1.1Rmh Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N * SJL
|
abnormal neural tube morphology |
J:169133
|
decreased somite size |
J:169133
|
open neural tube |
J:169133
|
Grem1tm1Ecan/Grem1tm1Ecan Nogtm1.1Rmh/Nogtm1.1Rmh Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N * SJL
|
abnormal brain development |
J:169133
|
abnormal head development |
J:169133
|
abnormal somite development |
J:169133
|
abnormal tail development |
J:169133
|
absent sclerotome |
J:169133
|
decreased somite size |
J:169133
|
kinked neural tube |
J:169133
|
open neural tube |
J:169133
|
Gt(ROSA)26Sortm1(Bcor*A)Vjba/Gt(ROSA)26Sor+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: 129S1/Sv * FVB/N
|
abnormal eye morphology |
J:296645
|
abnormal forelimb morphology |
J:296645
|
abnormal hindbrain morphology |
J:296645
|
embryonic lethality during organogenesis, complete penetrance |
J:296645
|
short mandible |
J:296645
|
short snout |
J:296645
|
Gt(ROSA)26Sortm1(Hesx1)Jpmb/Gt(ROSA)26Sor+ Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S/SvEv * C57BL/6 * SJL
|
exencephaly |
J:135132
|
Gt(ROSA)26Sortm1(Hesx1)Jpmb/Gt(ROSA)26Sortm1(Hesx1)Jpmb Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S/SvEv * C57BL/6 * SJL
|
exencephaly |
J:135132
|
Gt(ROSA)26Sortm1(Pim1-E2F1)Rebr/Gt(ROSA)26Sor+ Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * FVB * FVB/N
|
abnormal long bone epiphyseal plate proliferative zone |
J:83303
|
abnormal skeleton morphology |
J:83303
|
decreased body size |
J:83303
|
decreased width of hypertrophic chondrocyte zone |
J:83303
|
postnatal growth retardation |
J:83303
|
postnatal lethality, incomplete penetrance |
J:83303
|
Gt(ROSA)26Sortm1(Rybp/EGFP)Cve/Gt(ROSA)26Sor+ Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
cornea vascularization |
J:134428
|
Gt(ROSA)26Sortm1(Rybp/EGFP)Cve/Gt(ROSA)26Sortm1(Rybp/EGFP)Cve Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
abnormal vitreous body morphology |
J:134428
|
absent eye anterior chamber |
J:134428
|
cataract |
J:134428
|
coloboma |
J:134428
|
cornea vascularization |
J:134428
|
retina fold |
J:134428
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+ Snrpbem1Lajm/Snrpb+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: 129S4/SvJaeSor * C57BL/6J * CD1 * FVB/N
|
decreased cranial neural crest cell number |
J:326544
|
increased cranial neural crest cell apoptosis |
J:326544
|
Gt(ROSA)26Sortm7(CAG-mCherry,-EGFP/tetX)Dym/Gt(ROSA)26Sor+ Tmem163Tg(ACTB-cre)2Mrt/0 Tg(ACTFLPe)9205Dym/0
involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL
|
perinatal lethality |
J:154944
|
Gt(ROSA)26Sortm7(CAG-mCherry,-EGFP/tetX)Dym/Gt(ROSA)26Sor+ Tmem163Tg(ACTB-cre)2Mrt/0 Tg(Fev-flpe)1Dym/0
involves: 129S6/SvEvTac * FVB/N
|
abnormal axon morphology |
J:154944
|
abnormal breathing pattern |
J:231745
|
abnormal oxygen consumption |
J:231745
|
decreased anxiety-related response |
J:154944
|
decreased body size |
J:231745
|
decreased heart rate |
J:231745
|
enhanced contextual conditioning behavior |
J:154944
|
hypopnea |
J:231745
|
increased exploration in new environment |
J:154944
|
increased prepulse inhibition |
J:154944
|
increased pulmonary ventilation |
J:231745
|
increased susceptibility to induced morbidity/mortality |
J:231745
|
increased tidal volume |
J:231745
|
Kmt2dtm1.1Kaig/Kmt2d+ Tmem163Tg(ACTB-cre)2Mrt/0
B6.Cg-Kmt2dtm1.1Kaig Tg(ACTB-cre)2Mrt
|
abnormal heart echocardiography feature |
J:229890
|
normal
cardiovascular system phenotype |
J:229890
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig Tmem163Tg(ACTB-cre)2Mrt/0
B6.Cg-Kmt2dtm1.1Kaig Tg(ACTB-cre)2Mrt
|
absent head fold |
J:229890
|
absent somites |
J:229890
|
embryonic lethality between somite formation and embryo turning, complete penetrance |
J:229890
|
Lhx2tm1Monu/Lhx2tm1Monu Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * CD-1 * FVB/N
|
abnormal cerebral cortex morphology |
J:130167
|
abnormal telencephalon development |
J:130167
|
Lhx8tm1Vpa/Lhx8tm2.1Vpa Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * 129S4/SvJae * FVB/N
|
abnormal brain interneuron morphology |
J:182013
|
abnormal striatum morphology |
J:182013
|
Nfasctm2Bhat/Nfasctm2Bhat Tmem163Tg(ACTB-cre)2Mrt/0
involves: FVB/N
|
abnormal paranode morphology |
J:159621
|
Noc2ltm1.1Arte/Noc2ltm1.2Arte Tmem163Tg(ACTB-cre)2Mrt/0
involves: FVB/N
|
embryonic lethality prior to tooth bud stage, complete penetrance |
J:216490
|
Nogtm1.1Rmh/Nogtm1.1Rmh Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL
|
abnormal cartilage development |
J:169133
|
abnormal cartilage morphology |
J:169133
|
abnormal rib morphology |
J:169133
|
abnormal skeleton development |
J:169133
|
abnormal vertebrae morphology |
J:169133
|
Nxf2tm1.1JwNxf3tm1.1Jw/Y Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S4/SvJae * C57BL/6 * FVB/N
|
neonatal lethality, complete penetrance |
J:199138
|
Orc4tm1c(EUCOMM)Wtsi/Orc4tm1c(EUCOMM)Wtsi Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: C57BL/6N * FVB/N
|
abnormal female meiosis |
J:326522
|
abnormal oocyte morphology |
J:326522
|
abnormal polar body morphology |
J:326522
|
female infertility |
J:326522
|
Pbx1tm1.1Koss/Pbx1tm1.2Koss Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129P2/OlaHsd * FVB/N
|
abnormal deltoid tuberosity morphology |
J:184521
|
abnormal humerus morphology |
J:184521
|
abnormal rib morphology |
J:184521
|
abnormal scapula morphology |
J:184521
|
absent spleen |
J:184521
|
rib fusion |
J:184521
|
scapular bone hypoplasia |
J:184521
|
short ribs |
J:184521
|
Pthlhtm1Ack/Pthlhtm1.1Ack Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB/N
|
abnormal long bone epiphyseal plate morphology |
J:69396
|
abnormal long bone epiphyseal plate proliferative zone |
J:69396
|
distended abdomen |
J:69396
|
domed cranium |
J:69396
|
neonatal lethality, complete penetrance |
J:69396
|
premature endochondral bone ossification |
J:69396
|
protruding tongue |
J:69396
|
respiratory failure |
J:69396
|
short mandible |
J:69396
|
small thoracic cavity |
J:69396
|
Pthlhtm1Ack/Pthlhtm1Hmk Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129 * BALB/c * FVB/N
|
abnormal long bone epiphyseal plate morphology |
J:69396
|
abnormal long bone epiphyseal plate proliferative zone |
J:69396
|
disorganized long bone epiphyseal plate |
J:69396
|
distended abdomen |
J:69396
|
domed cranium |
J:69396
|
neonatal lethality, complete penetrance |
J:69396
|
premature endochondral bone ossification |
J:69396
|
protruding tongue |
J:69396
|
respiratory failure |
J:69396
|
short mandible |
J:69396
|
small thoracic cavity |
J:69396
|
Raph1tm1.1Makr/Raph1tm1.1Makr Tmem163Tg(ACTB-cre)2Mrt/0
involves: C57BL/6 * C57BL/6NTac * FVB/N
|
belly spot |
J:208191
|
decreased body size |
J:208191
|
postnatal lethality, incomplete penetrance |
J:208191
|
Raph1tm1.1Makr/Raph1tm1.1Makr Tmem163Tg(ACTB-cre)2Mrt/0 Tg(Dct-lacZ)A12Jkn/Tg(Dct-lacZ)A12Jkn
involves: C57BL/6 * C57BL/6NTac * CBA * FVB/N
|
belly spot |
J:208191
|
decreased body size |
J:208191
|
decreased melanocyte number |
J:208191
|
Setd5tm1c(EUCOMM)Wtsi/Setd5+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: C57BL/6N * FVB/N
|
abnormal cardiac outflow tract development |
J:314464
|
double outlet right ventricle |
J:314464
|
overriding aortic valve |
J:314464
|
perimembraneous ventricular septal defect |
J:314464
|
Setd5tm1c(EUCOMM)Wtsi/Setd5+ Tbx1tm1Bld/Tbx1+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: 129S7/SvEvBrd * C57BL/6 * FVB/N
|
abnormal cardiac outflow tract development |
J:314464
|
abnormal right subclavian artery morphology |
J:314464
|
double outlet right ventricle |
J:314464
|
normal
mortality/aging |
J:314464
|
overriding aortic valve |
J:314464
|
perimembraneous ventricular septal defect |
J:314464
|
Snrpbem1Lajm/Snrpb+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: C57BL/6J * CD1 * FVB/N
|
prenatal lethality, complete penetrance |
J:326544
|
Tcf4tm1Hmb/Tcf4+ Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
|
abnormal habituation to a new environment |
J:254983
|
decreased anxiety-related response |
J:254983
|
decreased body weight |
J:254983
|
decreased prepulse inhibition |
J:254983
|
decreased startle reflex |
J:254983
|
enhanced long-term potentiation |
J:254983
|
enhanced NMDA-mediated synaptic currents |
J:254983
|
impaired spatial learning |
J:254983
|
increased locomotor activity |
J:254983
|
Tex11tm1Jw/Tex11tm1Jw Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S4/SvJae * C57BL/6 * FVB/N
|
abnormal chiasmata formation |
J:131722
|
decreased litter size |
J:131722
|
Tex11tm1Jw/Y Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129S4/SvJae * C57BL/6 * FVB/N
|
abnormal chiasmata formation |
J:131722
|
arrest of male meiosis |
J:131722
|
decreased testis weight |
J:131722
|
increased male germ cell apoptosis |
J:131722
|
male infertility |
J:131722
|
meiotic nondisjunction during M1 phase |
J:131722
|
Tmem163Tg(ACTB-cre)2Mrt/0 Tg(Thy1-EYFP)15Jrs/0
involves: C57BL/6 * CBA * FVB/N
|
normal
nervous system phenotype |
J:89596
|